ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 2731

An Acetyl-Histone Mimetic Blocks Proinflammatory Activation Of Rheumatoid Arthritis Fibroblast-Like Synoviocytes

P. A. Kabala1, A.M. Grabiec1, C. Angiolilli1, Nicholas Smithers2, Jason Witherington3, Paul Peter Tak4, Rabinder Prinjha3 and Kris A. Reedquist5, 1Department of Experimental Immunology, Department of Clinical Immunology and Rheumatology Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, 2Immuno Inflammation, GlaxoSmithKline, Stevenage, United Kingdom, 3GlaxoSmithKline, Stevenage, United Kingdom, 4Academic Medical Center / University of Amsterdam, Department of Clinical Immunology and Rheumatology & GlaxoSmithKline, Amsterdam, Netherlands, 5Department of Experimental Immunology and Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Epigenetics, Histone Modification, rheumatoid arthritis (RA) and synovial cells, synovial fluid

  • Tweet
  • Email
  • Print
Session Information

Session Title: Biology and Pathology of Bone and Joint II: Osteoclast Biology and Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Genetic backgrounds and environmental factors do not completely explain the etiology of disease and predisposition to rheumatoid arthritis (RA), and increasing attention has turned to the potential contributions of heritable epigenetic mechanisms such as DNA methylation, post-translational modifications of histones, and expression of non-coding microRNAs. Fibroblast-like synoviocytes (FLS) isolated from affected joints of RA patients maintain an aggressive phenotype in vitro, indicating potential alteration of epigenetic regulatory processes, and changes in global and gene-specific promoter DNA methylation and histone modification are observed in RA FLS. I-BET compounds, acetyl histone mimetics which interfere with reading of acetylated histones by BET family bromodomain proteins BRD2-4, prevent LPS-induced inflammatory gene expression in murine bone marrow-derived macrophages in vitro, as well as in vivo models of endotoxic shock and bacterial sepsis. This study was undertaken to assess the potential of I-BET to influence the inflammatory activation of RA FLS. 

Methods: RA fibroblast-like synoviocytes (FLS) were treated with IL-1β or TNF in the presence or absence of increasing concentrations of I-BET, and IL-6 and IL-8 production measured by ELISA. Cellular viability was assessed using MTT assay and cell death ELISA kits. Activation of intracellular signaling pathways was examined by immunoblotting. Total RNA was extracted and mRNA expression of genes regulated by IL-1β or TNF in RA FLS was analyzed using a low density quantitative PCR custom array.

Results: BRD2-4 mRNA expression was readily detected in RA FLS. I-BET reduced RA FLS (n=6) production of IL-6 protein in response to IL-1β (1 μM, 70% reduction, P < 0.001) and TNF (50%, P < 0.001). IL-8 production in response to IL-1β (>75% reduction, P <. 0.001) and TNF (>70%, P < 0.001) was also inhibited. Similar effects were observed on IL-6 and IL-8 mRNA expression.  Inhibition of IL-6 and IL-8 production was maintained when I-BET treatment was delayed 1-4 hours post-stimulation. I-BET had no effect on cell viability or survival, and failed to modulate IL-1β or TNF–induced activation of MAPK or NF-κB signaling pathways.  Low density qPCR array analysis of 26 genes induced by IL-1β in RA FLS (n=3) demonstrated that I-BET reduced induction of 17 genes by >50%, including TNF (>80% suppression), MMP-1 (>90%), MMP-3 (90%), SELE (>80%), VCAM-1 (>60%), CXCL-6 (>75%), CXCL-9 (>95%) and CXCL-11 (>90%).

Conclusion: Our results demonstrate that disrupting the recruitment of BET family proteins to acetylated histones efficiently blocks RA FLS production of inflammatory mediators, including cytokines, chemokines and MMPs, in response to IL-1β and TNF.  This study provides initial evidence that the development of synthethic compounds targeting interactions between epigenetic modifications, such as histone acetylation, and the proteins which interpret these modifications may have therapeutic potential in the treatment of RA.


Disclosure:

P. A. Kabala,
None;

A. M. Grabiec,
None;

C. Angiolilli,
None;

N. Smithers,

GlaxoSmithKline,

3;

J. Witherington,

GlaxoSmithKline,

3;

P. P. Tak,

GlaxoSmithKline,

3;

R. Prinjha,

GlaxoSmithKline,

3;

K. A. Reedquist,

GlaxoSmithKline,

2.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/an-acetyl-histone-mimetic-blocks-proinflammatory-activation-of-rheumatoid-arthritis-fibroblast-like-synoviocytes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2022 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies